Aliases & Classifications for Endophthalmitis

MalaCards integrated aliases for Endophthalmitis:

Name: Endophthalmitis 12 55 51 41 14 69

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases
Orphanet: 55  
Rare eye diseases


External Ids:

Disease Ontology 12 DOID:4692
MeSH 41 D009877
NCIt 46 C34586
Orphanet 55 ORPHA199323
MESH via Orphanet 42 D009877
UMLS via Orphanet 70 C0014236
ICD10 via Orphanet 33 H44.0 H44.1
ICD10 32 H45.1
UMLS 69 C0014236

Summaries for Endophthalmitis

Disease Ontology : 12 A globe disease that is characterized by inflammation of the inside of the eye.

MalaCards based summary : Endophthalmitis is related to purulent endophthalmitis and corneal abscess, and has symptoms including redness or discharge of eye An important gene associated with Endophthalmitis is DEFB1 (Defensin Beta 1), and among its related pathways/superpathways are Development VEGF signaling via VEGFR2 - generic cascades and Fluid shear stress and atherosclerosis. The drugs Cefazolin and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and liver, and related phenotypes are hematopoietic system and immune system

Wikipedia : 72 Endophthalmitis is an inflammation of the interior of the eye. It is a possible complication of all... more...

Related Diseases for Endophthalmitis

Diseases in the Endophthalmitis family:

Chronic Endophthalmitis Acute Endophthalmitis

Diseases related to Endophthalmitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 183)
# Related Disease Score Top Affiliating Genes
1 purulent endophthalmitis 33.1 MRAP OPTN VEGFA
2 corneal abscess 30.0 DEFB1 PLG
3 neovascular glaucoma 29.6 OPTN VEGFA
4 vitreous detachment 29.6 PLG VEGFA
5 macular retinal edema 29.2 ICAM1 MRAP VEGFA
6 acute endophthalmitis 12.3
7 chronic endophthalmitis 12.3
8 phacoanaphylactic uveitis 11.3
9 cataract 10.6
10 sympathetic ophthalmia 10.5
11 heterophyiasis 10.4 ICAM1 SELE
12 lymphocytic vasculitis 10.4 ICAM1 SELE
13 mooren's ulcer 10.4 ICAM1 SELE
14 plummer's disease 10.4 ICAM1 SELE
15 hymenolepiasis 10.4 ICAM1 SELE
16 macrophage activation syndrome 10.4 HMGB1 PRF1
17 subendocardial myocardial infarction 10.4 ICAM1 SELE
18 actinic prurigo 10.4 ICAM1 SELE
19 rheumatoid vasculitis 10.3 ICAM1 SELE
20 osteonecrosis of the jaw 10.3 DEFB1 VEGFA
21 hypersensitivity reaction type iii disease 10.3 ICAM1 SELE
22 shwartzman phenomenon 10.3 ICAM1 SELE
23 localized scleroderma 10.3 DEFB1 SELE
24 cytomegalovirus infection 10.3 ICAM1 SELE
25 plasmodium vivax malaria 10.3 ICAM1 SELE
26 pneumonia 10.3
27 yemenite deaf-blind hypopigmentation syndrome 10.2 OPTN VEGFA
28 critical illness polyneuropathy 10.2 ICAM1 SELE
29 osgood-schlatter's disease 10.2 MRAP PRF1
30 spinal disease 10.2 MRAP VEGFA
31 retinitis 10.2
32 macular dystrophy, dominant cystoid 10.2 MRAP VEGFA
33 chronic myocardial ischemia 10.2 PLG VEGFA
34 cutaneous lupus erythematosus 10.2 ICAM1 SELE
35 diabetic macular edema 10.2 ICAM1 VEGFA
36 plague 10.1 PLG SELE
37 kuhnt-junius degeneration 10.1 PLG VEGFA
38 retinal vascular occlusion 10.1 PLG VEGFA
39 nodular goiter 10.1 ICAM1 VEGFA
40 keratitis, hereditary 10.1
41 uveitis 10.1
42 endotheliitis 10.1
43 hydrocele 10.1 ICAM1 SELE VEGFA
44 vitreous disease 10.1 PLG VEGFA
45 leukostasis 10.1 ICAM1 SELE VEGFA
46 iris disease 10.1 MRAP OPTN
47 hypopyon 10.1
48 meningitis 10.1
49 cellulitis 10.1
50 plantar fasciitis 10.0 CARD9 MRAP

Graphical network of the top 20 diseases related to Endophthalmitis:



Diseases related to Endophthalmitis

Symptoms & Phenotypes for Endophthalmitis

UMLS symptoms related to Endophthalmitis:


redness or discharge of eye

MGI Mouse Phenotypes related to Endophthalmitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.7 CARD9 GON4L ICAM1 PLG PRF1 SELE
2 immune system MP:0005387 9.56 CARD9 GON4L ICAM1 OPTN PLG PRF1
3 neoplasm MP:0002006 9.02 GON4L ICAM1 PLG PRF1 VEGFA

Drugs & Therapeutics for Endophthalmitis

Drugs for Endophthalmitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 191)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cefazolin Approved Phase 4 25953-19-9 33255 656510
2
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
3
Ephedrine Approved Phase 4,Phase 2 299-42-3 9294
4
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757
5
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2 57-63-6 5991
6
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 151096-09-2, 354812-41-2 152946
7
Norgestimate Approved, Investigational Phase 4,Phase 3,Phase 2 35189-28-7 6540478
8
Pseudoephedrine Approved Phase 4,Phase 2 90-82-4 7028
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 83-43-2 6741
10
Prednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 50-24-8 5755
11
Triamcinolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 124-94-7 31307
12
Iodine Approved, Investigational Phase 4 7553-56-2 807
13
Povidone Approved Phase 4 9003-39-8
14
Povidone-iodine Approved Phase 4 25655-41-8
15
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
16
Loteprednol Approved Phase 4 129260-79-3, 82034-46-6 9865442 444025
17
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
18
Ofloxacin Approved Phase 4 82419-36-1 4583
19
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
20
Bevacizumab Approved, Investigational Phase 4,Phase 2,Phase 3 216974-75-3
21
Ranibizumab Approved Phase 4,Phase 3,Phase 2,Phase 1 347396-82-1 459903
22
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
23
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
24
Bromfenac Approved July 1997 Phase 4,Phase 2 91714-94-2 60726
25 Anesthetics Phase 4
26 Anesthetics, Local Phase 4
27 Anti-Arrhythmia Agents Phase 4
28 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
29 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
30 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
31 Antitubercular Agents Phase 4,Phase 3
32 Central Nervous System Depressants Phase 4
33 Cephalosporins Phase 4
34 Diuretics, Potassium Sparing Phase 4
35 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
36 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2
37 Sodium Channel Blockers Phase 4
38 Autonomic Agents Phase 4,Phase 2
39 Contraceptive Agents Phase 4,Phase 3,Phase 2
40 Contraceptives, Oral Phase 4,Phase 3,Phase 2
41 Contraceptives, Oral, Combined Phase 4,Phase 3,Phase 2
42 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2
43 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2
44 Estradiol valerate Phase 4,Phase 3,Phase 2 979-32-8
45 Fluoroquinolones Phase 4,Phase 3,Phase 2
46 Nasal Decongestants Phase 4,Phase 2
47 Norgestimate, ethinyl estradiol drug combination Phase 4,Phase 3,Phase 2
48 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
49 Ophthalmic Solutions Phase 4,Phase 3,Phase 2,Phase 1
50 Polyestradiol phosphate Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 106)

# Name Status NCT ID Phase Drugs
1 Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain Unknown status NCT02324166 Phase 4 Cefazolin;Lidocaine
2 Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections Unknown status NCT00690313 Phase 4 Vigamox
3 IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids Unknown status NCT00744666 Phase 4 Prednisolone 1% topical eye drops
4 Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis Completed NCT00398658 Phase 4 gentamycin and clindamycin
5 Povidone-iodine Antisepsis for Strabismus Surgery Completed NCT00461656 Phase 4 Preoperative conjunctival irrigation with 5% or 1.25% PI
6 The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease Completed NCT02120079 Phase 4 Lotemax;Artificial Tears
7 Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora Completed NCT01739920 Phase 4
8 Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery Completed NCT00491049 Phase 4 0.5% levofloxacin eye drops
9 Aurolab Hydrophobic Foldable Intraocular Lens Study Completed NCT00449267 Phase 4
10 Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Completed NCT01722656 Phase 4 Aflibercept
11 Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis Recruiting NCT03363295 Phase 4 Moxifloxacin Injection
12 Bromfenac Versus Dexamethasone After Cataract Surgery Recruiting NCT03317847 Phase 4 Bromfenac 0.09 % Ophthalmic Solution;Dexamethasone 0.1% ophthalmic suspension
13 Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA Recruiting NCT03246152 Phase 4 Bevacizumab
14 Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease Recruiting NCT01738243 Phase 4 Hyaluronic Acid Gel injection;Saline injection
15 Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab Recruiting NCT02665689 Phase 4 ranibizumab
16 Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients Withdrawn NCT00304772 Phase 4 Fluconazole;Micafungin
17 Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis Unknown status NCT01768078 Phase 3
18 The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis Unknown status NCT00012506 Phase 3 TNFR:Fc
19 Endophthalmitis Vitrectomy Study (EVS) Completed NCT00000130 Phase 3 Intravitreal Antibiotics
20 Clinical Trial of Eye Prophylaxis in the Newborn Completed NCT00000120 Phase 3 Erythromycin Ointment;Silver Nitrate Drops
21 Retaane® in Age-Related Macular Degeneration Completed NCT00569569 Phase 2, Phase 3 juxtascleral depot injection of Retaane
22 Systemic Avastin Therapy in Age-Related Macular Degeneration Completed NCT00531024 Phase 2, Phase 3 Bevacizumab;Sodium Chloride
23 Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) Completed NCT00942864 Phase 3 ranibizumab
24 Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis Completed NCT00884585 Phase 3 Cyclosporine Vehicle;Cyclosporine 0.010%
25 Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis. Recruiting NCT02770729 Phase 3 Moxifloxacin;No injection of moxifloxacin
26 A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease Active, not recruiting NCT02307513 Phase 3 Apremilast (CC-10004);Placebo
27 Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery Not yet recruiting NCT03244072 Phase 2, Phase 3 Moxifloxacin;Placebo
28 Intracameral Antibiotic Safety Study Not yet recruiting NCT02590523 Phase 3 Vancomycin;Moxifloxacin;Placebo
29 Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa Terminated NCT01103063 Phase 3 Azithromycin plus chloroquine;sulfadoxine-pyrimethamine
30 The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy Unknown status NCT00849537 Phase 1, Phase 2 Triamcinolone
31 Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar Keratoplasty Unknown status NCT02424006 Phase 1, Phase 2
32 Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Unknown status NCT00349414 Phase 1, Phase 2
33 TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis Completed NCT00001862 Phase 2 Enbrel
34 Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients Completed NCT00001311 Phase 2
35 Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration Completed NCT00805233 Phase 2 combination ranibizumab + bromfenac;ranibizumab injection alone
36 Ranibizumab and Reduced Fluence PDT for AMD Completed NCT00527475 Phase 2 ranibizumab;verteporfin
37 Leflunomide to Treat Uveitis Completed NCT00001863 Phase 2 Leflunomide
38 Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00070759 Phase 2 Daclizumab
39 HAT in Eye Complications of Behcet's Disease Completed NCT00001865 Phase 2 Daclizumab
40 Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00043667 Phase 2 Daclizumab
41 RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery Completed NCT02065375 Phase 2 RTA 408 0.5% Ophthalmic Suspension;RTA 408 1.0% Ophthalmic Suspension;Placebo
42 Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis Completed NCT01789320 Phase 1, Phase 2 triamcinolone acetonide (Triesence®)
43 Safety and Efficacy of AIN457 in Noninfectious Uveitis Completed NCT00685399 Phase 2 AIN457;AIN 457;AIN457
44 Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis Recruiting NCT02595359 Phase 2 Moxifloxacin
45 Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study) Recruiting NCT02911116 Phase 2 Ustekinumab
46 Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis Terminated NCT01603355 Phase 1, Phase 2 Tocilizumab
47 Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate Terminated NCT01314417 Phase 1, Phase 2 Methotrexate
48 Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery Terminated NCT00431028 Phase 1, Phase 2
49 Ustekinumab for Active Sight-Threatening Uveitis Withdrawn NCT01647152 Phase 1, Phase 2 Ustekinumab
50 Lucentis for New Onset Neovascular Glaucoma Withdrawn NCT00727038 Phase 1, Phase 2 Ranibizumab (Lucentis)

Search NIH Clinical Center for Endophthalmitis

Cochrane evidence based reviews: endophthalmitis

Genetic Tests for Endophthalmitis

Anatomical Context for Endophthalmitis

MalaCards organs/tissues related to Endophthalmitis:

38
Eye, Endothelial, Liver, Testes, Thyroid, Lung, Retina

Publications for Endophthalmitis

Articles related to Endophthalmitis:

(show top 50) (show all 864)
# Title Authors Year
1
XEN Implant-Related Endophthalmitis. ( 29389405 )
2018
2
Diagnostic performance of blood culture bottles for vitreous culture compared to conventional microbiological cultures in patients with suspected endophthalmitis. ( 29318458 )
2018
3
Bacteriology and cefuroxime-resistance in endophthalmitis following cataract surgery before and after the introduction of prophylactic intracameral cefuroxime: a retrospective single-centre study. ( 29432821 )
2018
4
Exophiala dermatitidis Endophthalmitis: Case Report and Literature Review. ( 29374798 )
2018
5
A British Ophthalmological Surveillance Unit Study on metastatic endogenous endophthalmitis. ( 29328066 )
2018
6
Incidence of endophthalmitis after 23-gauge pars plana vitrectomy. ( 29361927 )
2018
7
Incidence of Endophthalmitis after Intravitreal Injections: Risk Factors, Microbiology Profile, and Clinical Outcomes. ( 29437495 )
2018
8
BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS. ( 29370030 )
2018
9
Trends in treatment strategies for suspected bacterial endophthalmitis. ( 29417214 )
2018
10
Late-onset postoperative Mycobacterium haemophilum endophthalmitis masquerading as inflammatory uveitis: a case report. ( 29415658 )
2018
11
Gas gangrene of the eye: endogenous <em>Clostridium perfringens</em> endophthalmitis. ( 29385972 )
2018
12
Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital. ( 29338030 )
2018
13
INCIDENCE OF ENDOPHTHALMITIS AFTER VITRECTOMY: A Systematic Review and Meta-analysis. ( 29370034 )
2018
14
Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient. ( 29359845 )
2018
15
Candida Endophthalmitis After Descemet Stripping Automated Endothelial Keratoplasty With Grafts From Both Eyes of a Donor With Possible Systemic Candidiasis. ( 29303885 )
2018
16
Endophthalmitis caused by Purpureocillium lilacinum. ( 29366691 )
2018
17
Pediatric Infectious Endophthalmitis: A Case Series. ( 29378081 )
2018
18
Surgical preferences in the management of recalcitrant endophthalmitis. ( 29300514 )
2018
19
Acute endophthalmitis after cataract surgery: 164 consecutive cases treated at a referral center in South Korea. ( 28548647 )
2017
20
Favorable Outcome in Coccidioides Endophthalmitis-A Combined Medical and Surgical Treatment Approach. ( 28872517 )
2017
21
Re: Haripriya etA al.: Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries (Ophthalmology. 2017;124:768-775). ( 28823359 )
2017
22
<i>Aeromonas Salmonicida</i> as a Causative Agent for Postoperative Endophthalmitis. ( 29422757 )
2017
23
UTILITY OF INTRAOPERATIVE OPTICAL COHERENCE TOMOGRAPHY IN ACUTE ENDOPHTHALMITIS. ( 28858193 )
2017
24
360 Degree Deep Corneal Vascularization In A Case Of Endophthalmitis With Corneal Abscess. ( 28718272 )
2017
25
EXOGENOUS MENINGOCOCCAL ENDOPHTHALMITIS: A CASE REVIEW. ( 28850051 )
2017
26
Acute Endophthalmitis Caused by<i>Leuconostoc</i>spp. following Intravitreal Bevacizumab Injection. ( 29282402 )
2017
27
Liver Abscess and Metastatic Endophthalmitis Secondary to Klebsiella pneumoniae K1. ( 28050045 )
2017
28
Treatment of Bacillus cereus endophthalmitis with endoscopy-assisted vitrectomy. ( 29390262 )
2017
29
Successful treatment of fungal endophthalmitis using intravitreal caspofungin. ( 28832730 )
2017
30
Severe corneal ulcer with progression to endophthalmitis and high-grade bacteremia. ( 29260050 )
2017
31
Endophthalmitis Following Strabismus Surgery: IPOSC Global Study. ( 28925741 )
2017
32
MALDI-TOF mass spectrometry for rapid diagnosis of postoperative endophthalmitis. ( 27989942 )
2017
33
BLEB-RELATED ENDOPHTHALMITIS AFTER USE OF THE INVITRIA INJECTION GUIDE. ( 28858192 )
2017
34
Endophthalmitis Progressing to Panophthalmitis: Clinical Features, Demographic Profile, and Factors Predicting Outcome. ( 29256717 )
2017
35
Comparison of methods for identifying causative bacterial microorganisms in presumed acute endophthalmitis: conventional culture, blood culture, and PCR. ( 28222703 )
2017
36
Re: Haripriya etA al.: Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: an analysis of 600a88000 surgeries (Ophthalmology. 2017;124:768-775). ( 28938934 )
2017
37
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231). ( 27993280 )
2017
38
Predictors of visual outcome and the role of early vitrectomy in Streptococcal endophthalmitis. ( 28949429 )
2017
39
Endophthalmitis Due to Proteus vulgaris after Pars Plana Vitrectomy with Devastating Outcome. ( 28936060 )
2017
40
POSTOPERATIVE ENDOPHTHALMITIS CAUSED BY BOSEA THIOOXIDANS. ( 28925927 )
2017
41
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231). ( 27993282 )
2017
42
Incidence of acute endophthalmitis after office based intravitreal bevacizumab injection. ( 29256542 )
2017
43
Successful management of post-traumatic vancomycin-resistant enterococcus endophthalmitis. ( 28848938 )
2017
44
Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. ( 28192644 )
2017
45
RESOLUTION OF TREATMENT-RESISTANT SUBRETINAL FLUID IN A PATIENT WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION FOLLOWING ENDOPHTHALMITIS. ( 28925926 )
2017
46
Endophthalmitis associated with Purpureocillium lilacinum during infliximab treatment for surgically induced necrotizing scleritis, successfully treated with 27-gauge vitrectomy. ( 28429128 )
2017
47
The Susceptibility of Bacterial Endophthalmitis Isolates to Vancomycin, Ceftazidime, and Amikacin: a 23 Year-Review. ( 28845474 )
2017
48
Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification. ( 28832735 )
2017
49
In response to: "Ranjan, P, Joshi P, and Gupta M. Staphylococcus aureus induced endogenous endophthalmitis with pink hypopyon." ( 28448724 )
2017
50
Clinical Features and Visual Acuity Outcomes in Culture-Positive Endogenous Fungal Endophthalmitis in Southern China. ( 28884023 )
2017

Variations for Endophthalmitis

Expression for Endophthalmitis

Search GEO for disease gene expression data for Endophthalmitis.

Pathways for Endophthalmitis

GO Terms for Endophthalmitis

Cellular components related to Endophthalmitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.26 HMGB1 ICAM1 PLG VEGFA
2 extracellular space GO:0005615 9.1 DEFB1 HMGB1 ICAM1 PLG SELE VEGFA

Biological processes related to Endophthalmitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 9.46 CARD9 DEFB1 HMGB1 OPTN
2 ovarian follicle development GO:0001541 9.32 ICAM1 VEGFA
3 positive chemotaxis GO:0050918 9.26 HMGB1 VEGFA
4 leukocyte cell-cell adhesion GO:0007159 8.96 ICAM1 SELE
5 positive regulation of receptor internalization GO:0002092 8.62 SELE VEGFA

Molecular functions related to Endophthalmitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.02 DEFB1 MRAP OPTN PRF1 VEGFA
2 chemoattractant activity GO:0042056 8.96 HMGB1 VEGFA

Sources for Endophthalmitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....